Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-α after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen (Q33488970)
Jump to navigation
Jump to search
scientific article published on June 1, 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-α after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen |
scientific article published on June 1, 1995 |
Statements
1 reference
Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen (English)
1 reference
Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-α after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen (English)
J. Atzpodien
E. Lopez Hänninen
H. Kirchner
A. Franzke
A. Körfer
M. Volkenandt
S. Duensing
A. Schomburg
S. Chaitchik
1 June 1995
1 reference
1 reference
31A
1 reference
876-881
1 reference
Identifiers
1 reference
1 reference